ADVERTISEMENT

Magnolia Diagnostics Settles False Claims Act Allegations Over COVID Tests for $24 Million Combined

ADVERTISEMENT

Magnolia investors will pay an additional $4.8 million to resolve common law claims for unjust enrichment and payment by mistake and claims under the Federal Debt Collection Procedures Act, arising from distributions they received from Magnolia.

“The Justice Department is committed to protecting taxpayer-funded programs and holding accountable those continue reading …

ADVERTISEMENT

Leave a Comment

ADVERTISEMENT